Brief: Rallybio Announces Results Demonstrating FNAIT Risk Across Racially And Ethnically Diverse Populations
17/06/2024 13:08
June 17 (Reuters) - Rallybio Corp RLYB.O :
* RALLYBIO ANNOUNCES RESULTS OF EPIDEMIOLOGICAL ANALYSIS
DEMONSTRATING FNAIT RISK ACROSS RACIALLY AND ETHNICALLY DIVERSE
POPULATIONS
* RALLYBIO CORP: TOPLINE RESULTS SUGGEST SIGNIFICANT
INCREASE IN
NUMBER OF PREGNANCIES AT HIGHER RISK FOR FNAIT ANNUALLY AND
RLYB212 ADDRESSABLE MARKET
* RALLYBIO CORP: ON TRACK TO INITIATE RLYB212 PHASE 2 DOSE
CONFIRMATION STUDY IN PREGNANT WOMEN AT HIGHER RISK FOR FNAIT IN
2H 2024
Source text for Eikon: ID:nBwbJdtQBa
Further company coverage: RLYB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx